期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

复发胰腺癌和前列腺癌再放疗中脉冲式低剂量率(PLDR)调强治疗计划的设计和应用 被引量：4

IMRT for Recurrent Pancreas and Prostate Cancer Using Pulsed Low Dose Rate Delivery Techniques
原文传递
导出
摘要 目的:设计一种用于复发的胰腺癌和前列腺癌放射治疗的PLDR-IMRT计划。方法:选择10例复发胰腺癌和10例复发前列腺癌患者,每个计划设置10个非共面射野,采用各种优化手段使得计划满足PLDR治疗的要求。并与三维适形(PLDR-3DCRT)计划和旋转调强(PLDR-ARC)计划比较。结果:胰腺癌PLDR-IMRT计划中,每个单独的射野中PTV的平均剂量在17.6cGy到22.4cGy之间,最大剂量的范围从22.9cGy到34.8cGy。前列腺癌病例中,PTV在每个单独的射野中的平均剂量在18.8cGy到22.6cGy之间,最大剂量的范围从24.0cGy到34.7cGy。IMRT计划中危及器官的剂量大大小于三维适形计划,接近旋转调强计划。结论:在脉冲式低剂量率放射治疗中,通过优化的设计,IMRT计划相对于通常使用的3DCRT计划更有优势,在保证靶区剂量的基础上降低了危及器官受量。 Objective： To investigate the planning techniques for IMRT-based PLDR treatment for recurrent pan-creatic and prostate cancer cases. Methods：Ten cases of recurrent recurrent pancreatic and 10 cases of prostate cancer pa-tients were included in this study. Treatment plans were generated with 10 gantry angles using the step-and-shot delivery technique, which can be delivered in three-minute intervals to achieve an effective low-dose rate. The IMRT plans were compared with the 3DCRT plans and ARC plans. Results：For the ten pancreas cases investigated, the mean PTV dose for each gantry angle in the IMRT plans ranged from 17. 6 cGy to 22. 4 cGy. The maximum doses ranged between 22. 9 cGy and 34. 8 cGy. For the ten prostate cases investigated, the mean PTV doses for individual gantry angles ranged from 18. 8 cGy to 22. 6 cGy. The maximum doses per gantry angle were between 24. 0 cGy and 34. 7 cGy. A significant reduction in the OAR dose was achieved with IMRT compared with 3DCRT. Conclusion：Compared with 3DCRT, IMRT could provide superior target coverage and normal tissue sparing for PLDR reirradiation of recurrent pancreatic and prostate cancers.
作者 黎杰 康盛伟 谭志博 王俊超 廖雄飞 王培
机构地区 四川省肿瘤医院放疗科
出处 《肿瘤预防与治疗》 2014年第3期120-125,共6页 Journal of Cancer Control And Treatment
基金 四川省卫生厅项目 编号:090533
关键词 再放疗 脉冲式低剂量率 调强放射治疗 Reirradiation Pulsed Low Dose Rate （ PLDR） PLDR-IMRT
分类号 R730.55 [医药卫生—肿瘤] R735.9 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Richards GM,Tome WA,Robins HI,et al.Pulsed reduced dose-rate radiotherapy:a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall,axilla,or supraclavicular region [ J].Breast Cancer Res Treat,2009,114(2):307-313.
  • 2Nieder C,Milas E,Aug KK.Tissue tolerance to reirradiation[ J ].Semin Radiat Oncol,2000,10(2):200-209.
  • 3Marks LB,Ten Haken RK,Martel MK.Quantitative analyses of normal tissue effects in the clinic [ J ].Suppl Int J Radiat Oncol Biol Phys,2010,76(1):S1-S160.
  • 4Tome WA,Howard SP.On the possible increase in local turnout control probability for gliomas exhibiting low dose hyperradiosensi-tivity using a pulsed schedule[J].Br J Radiol,2007,80(1):32-37.
  • 5Hall EJ,Giaccia AJ.Radiobiology for the radiologist,6th ed [ M].Philadelphia:Lippincott Williams & Wilkius,2006:352-370.
  • 6Joiner MC,Marples B,Lambin P,et al.Low-dose hypersensitivi-ty:current status and possible mechanisms[ J].Int J Radiat Oncol Biol Phys,2001,49(2):379-389.
  • 7Resch A,Fellner C,Mock U,et al.Locally recurrent breast cancer:pulsed dose rate brachytherapy for repeat irradiation fol-lowing lumpectomy-a second chance to preserve the breast [ J ].Radiology,2002,225(3):713-718.
  • 8Marples B.Is low-dose hyper-radiosensitivity a measure of G2-phase cell radiosensitivity? [ J].Cancer Metastasis Rev,2004,23(1)197-207.
  • 9Harney 3,Short SC,Shah N,et al.Low dose hyper-radiosensitiv-ity in metastasis tumors[ J].Int J Radiat Oncol Biol Phys,2004,59(4):1190-1195.
  • 10Peiffert D,Castelain B,Thomas L,et al.Pus]ed dose rate brachytherapy in head and neck cancer:Feasibility study of a French cooperative group[ J].Radiother Oncol,2001,58(1):71-75.

同被引文献30

  • 1Richards GM, Tome WA, Robins HI, et al. Pulsed reduced doserate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region [ J ]. Breast Cancer Res Treat, 2009, 114(2) :307-313.
  • 2Nieder C, Mi|as L, Ang KK. Tissue tolerance to reirradiation [J].Semin Radiat Oncol, 2000,10(2) :200-209.
  • 3Marks LB, Ten HakenRK, Martel MK. Quantitative analyses of normal tissue effects in the clinic [ J ] . Suppl Int JRadiat Oncol Biol pHys ,2010,76 ( 1 ) : S1-S160.
  • 4Tome WA, Howard SP. On the possible increase in local tumour control probability for gliomas exhibiting low dose hyperrediosensitivity using a pulsed schedule [ J ]. Br J Radiol, 2007,80( 1 ) :32-37.
  • 5Joiner MC, Marples B, Lambin P, et al. Low - dose hypersensitivity:current status and possible mechanisms[J] . Int J Radiat Oneol BiolpHys,2001,49 (2) :379-389.
  • 6Rasch A,Fellner C,Mock U,et al. Locally recurrent breast cancer: pulsed dose rate braebytheralpy for repeat irradiation following lumpectomy- a second chance to preserve the breast [ J ]. Radiolagy,2002,225 (3) :713-718.
  • 7Marples B. Is low - dose hyper - radiosensitivity a measure of G2 - phase cell radiosensitivity [ J ]. Cancer Metastasis Rev, 2014,3 ( 1 ) : 197-207.
  • 8Cannon GM, Tome WA, Robins HI, et al. Pulsed reduced doserate radiotherapy:case report, a novel re - treatment strategy in the management of recurrent glioblastoma multiforme [ J ]. J Neurol Oncol,2007,83 (2) :307-311.
  • 9Adkison JB, Tome W, Seo S, et al. Reirradiation of large - volumerecurrent glioma with pulsed reduced - dsee - rate radiotherapy [J]. Int J Radiat Oncol Biol pHys,2011,79(3) :835-841.
  • 10Ma CM, Lin MH, Dai XF, et al. Investigation of poised low dose rate radiotherapy using dynamic arc delivery techniques [ J ]. pHys Med Biol,2012,57(14) :4613-4626.

引证文献4

二级引证文献1

肿瘤预防与治疗
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部